ISA has been shown to exert both a potent pro-apoptotic effect, regardless of the presence of cross-linking agents, and robust ADCC (the most prevalent effector mechanism for the elimination of tumor plasma), CDC and ADCP against CD38+ malignant subpopulations [8]. This evidence concerns the gene CD38 and neoplasm.